Primary Job Title Chairman Primary Organization Kuros Biosciences
Location Switzerland, Europe Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Fritz Kunz started his professional career at Sandoz Pharma, Basel, in 1971 where he held numerous positions in research and development management. In 1992, Fritz Kunz became chief financial officer at Stratec Medical. From 1994 to 1998, he was CEO and a member of the Board of Directors of Institute Straumann. In 1998 Fritz Kunz became a member of
the Board of Directors of Speedel and Chairman from 2000 to 2008 when the company was acquired by Novartis.
He is also Chairman of Kuros and Numab and a member of the Board of Sentec. Fritz Kunz holds a PhD in bioorganic chemistry from the ETH Zürich and was a postdoctoral fellow at Yale University, New Haven, Conn., USA. Post-graduate studies included the Advanced Management Programme INSEAD and Finance for Executives INSEAD at Fontainebleau.
